CLINICAL_TRIALS
trial_result
· 2011-10-19
Clinical Trial Update: Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection [Phase 2]
Summary
Phase 2 clinical trial results report safety and efficacy of PP4001 for the treatment of symptoms associated with uncomplicated urinary tract infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pinnacle Pharmaceuticals, Inc. | Conditions: Urinary Tract Infection | Phase 2 | Status: COMPLETED